Riskpilot← Back to searchSign inGet full accessResMed Sweden AB
ABActiveOrg 5565822920Jan Stenbecks Torg 17 12 TrWholesale of pharmaceutical and medical goods · NACE 4646Est. 199921 employees
Revenue 2025
SEK 278,7M
+19% vs 2024
EBITDA margin
4.7%
+32% vs 2024
Equity ratio
62.7%
Financial strength
Net profit 2025
SEK 9,7M
+28% vs 2024
| Revenue | SEK 278,7M | +19% |
| EBITDA | SEK 13M | +32% |
| Net profit | SEK 9,7M | +28% |
| Total assets | SEK 91,6M | +5% |
| Equity | SEK 57,4M | +20% |
| Employees | 21 | — |
Legal name
ResMed Sweden AB
Org number
5565822920
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27 december 1999
Share capital
SEK 8 740 000
Employees
21 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva tillverkning, försäljning och distrution av medicinsk utrustning samt därmed förenlig verksamhet.
Address
Jan Stenbecks Torg 17 12 Tr
Phone
+4684771000
Email
reception@resmed.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 170 471 | 191 235 | 265 909 | 234 075 | 278 672 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 7 670 | 8 608 | 10 652 | 9 801 | 12 965 |
| Depreciation & amort. | −111 | −202 | −166 | −215 | −1 544 |
| EBIT | 7 559 | 8 406 | 10 486 | 9 586 | 11 421 |
| Net financials | −257 | −789 | 299 | 84 | 888 |
| Profit before tax | 7 302 | 7 617 | 10 785 | 9 670 | 12 308 |
| Tax | −1 595 | −1 606 | −2 287 | −2 115 | −2 631 |
| Net profit | 5 707 | 6 011 | 8 498 | 7 555 | 9 677 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 51 442 | 102 026 | 113 560 | 87 582 | 91 592 |
| Equity | 25 643 | 31 654 | 40 152 | 47 707 | 57 385 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 25 799 | 70 371 | 73 407 | 39 874 | 34 207 |
| Total debt | 25 799 | 70 371 | 73 407 | 39 874 | 34 207 |
EBITDA margin
4.7%
This company
15.8%
Market median
-70% vs market
20212025
Equity ratio
62.7%
This company
38.2%
Market median
+64% vs market
20212025
Return on equity
16.9%
This company
18.4%
Market median
+8% vs market
20212025
Net profit margin
3.5%
This company
8.1%
Market median
-57% vs market
20212025
Asset turnover
3.04×
This company
1.12×
Market median
+171% vs market
20212025
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2024 |
JF Chief Auditor | Chief Auditor | 2024 |
KR Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (3) | ||
ME Chief Auditor | Chief Auditor | 2021 – 2024 |
NP Authorized Recipient of Service | Authorized Recipient of Service | 2023 – 2024 |
NP Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
RESMED CAPITAL HOLDINGS LTD
ResMed Sweden AB (this company)Board members of ResMed Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Erik Sture Kåvik | Chief Auditor | 0 companies |
| Jussi Antero Vuorela | Deputy Chief Executive Officer | 0 companies |
| Nils Per Olof Hedman | Authorized Recipient of Service | 0 companies |
| Johan Fredrik Wollmann | Chief Auditor | 0 companies |
| Karl Rickard Handin | Chief Executive Officer | 0 companies |
| Nina Pernilla Medson | Chief Executive Officer | 0 companies |
| Andrew David Huxter | Board of Directors | 0 companies |
| Michael James Rider | Chairman | 0 companies |
| David Brian Pendarvis | Chairman | 0 companies |